The invention relates to a packaging comprising a multitude
(A) of at least 2 administration units comprising polymorphic trihydrated forms of sodium salt of 4-tert-butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzenesulfonamide; or
(B) of at least 2 administration units comprising polymorphic solvated or desolvated forms of sodium salt of 4-tert-butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzenesulfonamide.
本发明涉及一种包装,它包括多个
(A) 至少 2 个给药单元,包含 4-叔丁基-N-[4-
氯-2-(1-氧代
吡啶-4-羰基)-苯基]-苯磺酰胺钠盐的多晶型三
水合物;或
(B) 至少 2 个给药单元,包括 4-叔丁基-N-[4-
氯-2-(1-氧基
吡啶-4-羰基)-苯基]-苯磺酰胺钠盐的多晶溶解或脱溶形式。